Trials / Completed
CompletedNCT03373201
Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 320 (actual)
- Sponsor
- Vanda Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to investigate tasimelteon vs. placebo on sleep in healthy individuals after a phase advance in jet lag type insomnia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tasimelteon | Oral capsule |
| DRUG | Placebo | Oral capsule |
Timeline
- Start date
- 2017-10-16
- Primary completion
- 2018-03-05
- Completion
- 2018-03-05
- First posted
- 2017-12-14
- Last updated
- 2023-09-15
- Results posted
- 2023-09-15
Locations
12 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03373201. Inclusion in this directory is not an endorsement.